Skip Navigation
Search site

We are building you a better website. You might be interested to see the new look here, and let us know what you think.

National Diabetes Audit

The National Diabetes Audit (NDA) is the one of the largest annual clinical audits in the world, integrating data from both primary and secondary care sources, making it the most comprehensive audit of its kind.

To find out more about the NDA Programme check out this short presentation, or view a power point presentation here     


What's New?

The 2016-17 NDA Collection is now closed

The 2016-17 collection of the NDA is now closed. We opened for submissions on 14 June 2017,and the submission deadline was 28 July 2017.The NDA team would like to thank everyone who participated in the audit and for all the support the audit has received.

The National Diabetes Audit Insulin Pump Report 2015-16

The Insulin Pump Audit collects information on the number of people with diabetes using an insulin pump, the reason for going on an insulin pump and the outcomes achieved since starting the pump. The report and supporting documentation is available here 

National Diabetes Audit Complications and Mortality 2015-2016 Report

This report, Report 2a and an accompanying Report 2b, from the National Diabetes Audit (NDA) covers complications of diabetes. The reports and supporting documentation are available here 

National Diabetes Audit - 2015-2016: Report 1, Care Processes and Treatment Targets

The National Diabetes Audit 2015-2016 Report presents the key findings and recommendations for care process completion and treatment target achievement, along with the number of offers and attendances at structured education in England and Wales. For the first time, we have also reported on people with diabetes who also have a learning disability.

The reports and supporting documentation can be found here. An interactive dashboard displaying key points can be found here

National Diabetes Audit - 2015-2016: Report 1, Care Processes and Treatment Targets

82.4 per cent of general practices in England and Wales participated in the 2015-2016 National Diabetes Audit. You can find out more information about 2015-16 participation for your region here, or by viewing an interactive dashboard which displays participation rates for the past 3 years, broken down by the CCG or LHB of your choice here

Please see the link on the right hand side "Access the Audit Reports" to find reports for previous audit years


What does the NDA measure?

The National Diabetes Audit is a major national clinical audit which measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. The NDA collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes.

The NDA answers five key questions:-

  • Is everyone with diabetes diagnosed and recorded on a practice diabetes register?
  • What percentage of people registered with diabetes received the nine National Institute of Health and Care Excellence (NICE) key processes of diabetes care?
  • What percentage of people registered with diabetes achieved NICE defined treatment targets for glucose control, blood pressure and blood cholesterol?
  • What percentage of people registered with diabetes are offered and attend a structured education course?
  • For people with registered diabetes what are the rates of acute and long term complications (disease outcomes)?

Aims and Objectives

The NDA supports improvement in the quality of diabetes care by enabling participating NHS services and organisations to:

  • assess local practice against NICE guidelines
  • compare their care and care outcomes with similar services and organisations
  • identify gaps or shortfalls that are priorities for improvement
  • identify and share best practice
  • provide comprehensive national pictures of diabetes care and outcomes in England and Wales

Through participation in the audit, local services are able to benchmark their performance and identify where they are performing well and improve the quality of treatment and care they provide.

A Quality Improvement Toolkit has been developed in collaboration with the RCGP to help practices use their diabetes data to improve services http://www.rcgp.org.uk/clinical-and-research/toolkits/quality-improvement-toolkit-for-diabetes-care.aspx


Who manages the audit?

The National Diabetes Audit (NDA) is commissioned and managed under an agreement by the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England and the Welsh Government. The NDA is delivered by NHS Digital (previously known as 'the Health and Social Care Information Centre, HSCIC'), in partnership with Diabetes UK and the National Cardiovascular Intelligence Network (part of Public Health England).


Analysing your data

A series of reports are available in the catalogue that will provide you with information on:

  • Audit participation in primary and secondary care

Data tables with information on:

  • care processes (percentage recorded)
  • HbA1c results
  • patient age distribution
  • average age and BMI
  • diabetes type distribution
  • ketoacidosis episodes

Further in-depth analysis at a national and local level on:

  • registration and prevalence
  • complications
  • care processes
  • treatment targets

Data Access Requests

If you require access to the NDA dataset, please complete the data request form below. This form should be used when applying for the National Diabetes Audit data and should be completed alongside the Data Access Request Form which is available from the Healthcare Quality Improvement Partnership website. http://www.hqip.org.uk/national-programmes/a-z-of-nca/audits-and-data-gov-uk/

xls icon NDA Data Access Request Form [1Mb]

Please submit completed forms to diabetes@nhs.net. If you would like to discuss your application before you submit, please contact the NDA team. You can email diabetes@nhs.net or telephone 0300 303 5678 and ask to speak to a member of the NDA team.


Use of Audit Tools and Documentation Outside of the Clinical Audit

You hereby agree that in downloading or using the documents or tools on this web page for any use outside of the project for which it was developed, you are entering into a royalty free, non-exclusive, licence agreement with the Healthcare Quality Improvement Partnership under the following Terms and Conditions:
 
All information, software, products and related graphics contained in the audit tool or data collection form are provided for non commercial purposes  "as is" without warranty, including but not limited to the implied warranties of satisfactory quality, fitness for a particular purpose, title and non-infringement of third party intellectual property rights. In no event shall HQIP be liable for any direct, indirect, incidental, special or consequential damages for loss of profits, revenue, data or use incurred by you or any third party, whether in action in contract, tort, or otherwise, arising from your access to, or use of, the audit tool or form. HQIP make no representations about the suitability, reliability, or timeliness, and accuracy of the information, software, products and related graphics contained in the audit tool or forms. HQIP reserves the right to make improvements, changes or updates to forms or tools at any time without notice.

Close iCM Form